FibroBiologics, Inc. Common Stock logo

FBLGFibroBiologics, Inc. Common Stock

FBLG Stock Price, Valuation & Chart | FibroBiologics, Inc. Common Stock

Compare

FBLG Historical price chart

FBLG Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization4.09M
PE Ratio-0.35
EPS-5.57
Trading Volume633.58K
Today's High/Low2.17/1.86
Dividend Yield0.00
52 Week High/Low12.42/0.62
Shares Outstanding2.10M
FBLG Financial Statement
FBLG Analyst ratings
FBLG Analysis & performance metrics

FBLG Company profile

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the…

FBLG Management team

Management
Peter O'HeeronCEO
Founder, Chairperson & Chief Executive Officer
Total 1 executive

FBLG Frequently asked questions

What is FibroBiologics, Inc. Common Stock (FBLG) Stock Price?

Current stock price of FibroBiologics, Inc. Common Stock (FBLG) stock is $1.950. The stock price is -7.58% lower in the session. The intraday range can be seen from this page. Volume of FibroBiologics, Inc. Common Stock (FBLG) stock is 633.58K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the FibroBiologics, Inc. Common Stock (FBLG) stock price going up or down today?

The stock price of FibroBiologics, Inc. Common Stock (FBLG) can change with earnings, company news, and overall market sentiment. FibroBiologics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the FibroBiologics, Inc. Common Stock stock expensive at its current price?

Whether FibroBiologics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for FBLG on this page is -0.35. EPS on this page is -5.57. Compare those figures with peers and growth expectations before deciding if the current FibroBiologics, Inc. Common Stock price is justified.

How has the stock price of FibroBiologics, Inc. Common Stock (FBLG) performed historically?

Historical performance for FibroBiologics, Inc. Common Stock (FBLG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how FBLG reacted to past earnings and market events.

Should I buy FibroBiologics, Inc. Common Stock (FBLG) stock, at this price?

Buying FibroBiologics, Inc. Common Stock (FBLG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.